2 Department of Medicine, Faculty of Medicine, Semmelweis University Szentkirályi str. 46. H-1088 Budapest, Hungary.
Am J Cancer Res. 2011;1(5):618-28. Epub 2011 Apr 25.
Adrenocortical cancer is a rare tumor and its prognosis is poor. Although numerous tumor-associated genetic and signal transduction alterations have been described to date, its pathogenesis is still unclear. Hybridization-based DNA microarray approaches may reveal significant gene expression alterations and may thus contribute to a better understanding of tumorigenesis and may identify molecular markers applicable for the distinction of benign and malignant lesions. Beside gene expression patterns, studies on microRNAs seem to be useful, as well. Novel therapeutical targets might be established by these approaches. In this review, the authors attempt to summarize the main findings of mRNA and microRNA expression microarray studies performed to date in adrenocortical cancer including a recent meta-analysis of gene expression data and present novel pathogenic pathways.
肾上腺皮质癌是一种罕见的肿瘤,其预后较差。尽管迄今为止已经描述了许多与肿瘤相关的遗传和信号转导改变,但它的发病机制仍不清楚。基于杂交的 DNA 微阵列方法可能揭示显著的基因表达改变,从而有助于更好地理解肿瘤发生,并可能确定适用于良性和恶性病变区分的分子标志物。除了基因表达模式外,microRNAs 的研究似乎也很有用。这些方法可能会建立新的治疗靶点。在这篇综述中,作者试图总结迄今为止在肾上腺皮质癌中进行的 mRNA 和 microRNA 表达微阵列研究的主要发现,包括最近对基因表达数据的荟萃分析,并提出新的发病途径。